Mineralys Therapeutics, Inc. (MLYS)

NASDAQ: MLYS · IEX Real-Time Price · USD

13.20

-0.42 (-3.08%)

At close: Jul 19, 2024, 4:30 PM

13.28

+0.08 (0.61%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Mineralys Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	90.42	49.3	87.7	10.61	1.41
Short-Term Investments	248.15	187.26	22.41	0	0
Cash & Cash Equivalents	338.57	236.57	110.11	10.61	1.41
Cash Growth	25.10%	114.85%	937.60%	653.16%	-
Other Current Assets	8.25	12.54	2.7	0.51	0.06
Total Current Assets	346.82	249.1	112.81	11.12	1.47
Property, Plant & Equipment	0.05	0	0	0	0
Long-Term Investments	0	2.48	0	0	0
Other Long-Term Assets	0.38	0.05	1.63	0	0.02
Total Long-Term Assets	0.43	2.53	1.63	0	0.02
Total Assets	347.25	251.64	114.44	11.13	1.49
Accounts Payable	4.26	0.6	1.91	0.76	0.53
Current Debt	0	0	0	0	4.5
Other Current Liabilities	14.94	9.88	6.16	4.29	0.05
Total Current Liabilities	19.2	10.48	8.07	5.05	5.08
Other Long-Term Liabilities	0	0	158.64	29	0
Total Long-Term Liabilities	0	0	158.64	29	0
Total Liabilities	19.2	10.48	166.71	34.05	5.08
Total Debt	0	0	0	0	4.5
Retained Earnings	-156.22	-124.71	-52.81	-23.01	-3.6
Shareholders' Equity	328.05	241.15	-52.27	-22.93	-3.6
Net Cash / Debt	338.57	236.57	110.11	10.61	-3.09
Net Cash / Debt Growth	25.10%	114.85%	937.60%	-	-
Net Cash Per Share	7.54	6.54	21.31	2.13	-0.06
Working Capital	327.62	238.62	104.74	6.07	-3.62
Book Value Per Share	7.31	6.66	-10.12	-4.60	-0.07

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).